Tag Archives: Aphria Inc.

Europe’s population dwarfs that of both Canada and the U.S combined and it is predicted that over the next 5 years the CBD industry will grow more than 400% through 2023 in Europe (source) that will make it the largest legal cannabis market in the world. This is a great opportunity for companies to enter and expand through Europe with far less competition than we’re seeing in the U.S. and Canada.

43% of the 135 medical & recreational marijuana/cannabis "pot' stocks trade on Canada's TSE, TSXV, CSE and NEO exchanges for at least $1/share but only 16 of them trade above $5/share. This article identifies them and provides pertinent data and links to their web sites.

These 8 stocks, by the fact that they are listed on major stock exchanges in both Canada and the U.S., are well placed to attract major institutional attention and the potential for major price appreciation as more investors get on board. It might serve new investors well to seriously consider these stocks instead of venturing into the much more volatile juniors in the space.

As legalization approaches cannabis companies must compete for supply agreements and retail space...[and those companies best] increasing their production and sales to meet demand could capture a strong retail presence early on. The Canadian cannabis stocks on our list today have released their financial results recently, giving investors insight into their production and revenue increases.

Today we have identified seven Canadian cannabis producers based on sale cost and production efficiency.

As recreational legalization in Canada approaches this summer, the 4 marijuana stocks on our list today have plans to meet the upcoming demand. If the marijuana sector continues its rally, these stocks...are expected to generate significant EBITDA growth over the coming year.

With intraday fluctuations of up to 80% - yes, 80% - the Canadian marijuana stocks on our list create significant day-trading opportunities for those so inclined.